Meta-Learners for Estimation of Causal Effects: Finite Sample Cross-Fit Performance
In recent years there has been a growing interest in the estimation of causal effects using machine learning algorithms, particularly in the field of economics (Athey, 2018). The newly emerging synthesis of machine learning methods with causal inference has a large potential for a more comprehensive estimation of causal effects (Lechner, 2018). On the one hand, it enables a more flexible estimation of average effects which are of main interest in microeconometrics (Imbens & Wooldridge, 2009). On the other hand, it advances the estimation beyond the average effects and allows for a systematic analysis of effect heterogeneity (Athey & Imbens, 2017). Both of these aspects contribute to a better description of the causal mechanisms and thus to a possibly more efficient treatment allocation (Zhao, Zeng, Rush, & Kosorok, 2012; Kitagawa & Tetenov, 2018; Athey & Wager, 2021; Nie, Brunskill, & Wager, 2021). Hence, applied empirical researchers can greatly benefit from the usage of machine learning methods ranging from evaluation of public policies and business decisions to designing personalized interventions (Andini, Ciani, de Blasio, D'Ignazio, & Salvestrini, 2018; Bansak et al., 2018). Machine learning estimators as such are, however, primarily designed for prediction problems and thus cannot be used directly for causal inference. Therefore, new approaches for the estimation of causal parameters using machine learning emerged (see Athey & Imbens, 2019, for an overview). In particular, the development of the so-called meta-learners have received considerable attention (see e.g.
Jan-29-2022
- Country:
- Europe
- Belgium (0.04)
- Germany > North Rhine-Westphalia
- Upper Bavaria > Munich (0.04)
- Italy (0.04)
- Switzerland > Vaud
- Lausanne (0.04)
- North America > United States
- Illinois > Cook County > Chicago (0.04)
- Europe
- Genre:
- Research Report
- Experimental Study (1.00)
- New Finding (1.00)
- Research Report
- Industry:
- Education (1.00)
- Government (0.65)
- Health & Medicine
- Epidemiology (0.46)
- Pharmaceuticals & Biotechnology (0.67)
- Technology: